We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.45 | 3.40 | 3.50 | 3.45 | 3.45 | 3.45 | 1,543,287 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.32 | 3.11M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/7/2022 07:23 | Plenty holdings the baby here .... | amaretto1 | |
28/7/2022 07:22 | I'd say 5 pence max .... | amaretto1 | |
27/7/2022 16:39 | Looks closer to getting into single figures than the teens to be honest | tburns | |
27/7/2022 16:27 | ah there is the big sell had to be, hopefully the last of the placing shares | ianjan | |
27/7/2022 16:12 | The market is always on the ball and can see this shambles from what it is that is why we are heading back into the teens!! | pinkpudycat | |
27/7/2022 15:57 | whats with the trades today over 350k more buys than sells yet we are down must be a large sell after hours, hopefully to clear whoever is still selling down here | ianjan | |
27/7/2022 15:53 | Added a little today . An easy bagger from here in the near term . | jungmana | |
27/7/2022 14:14 | Exactly mate | ben gibbons | |
27/7/2022 07:19 | PM2022 on the last twitter rampathon 60/40 split in favour of it being true I remember you stating.Hope you never play Russian roulette because I don't favour your odds of winning bro ;-) | ben gibbons | |
27/7/2022 07:12 | What a massive surprise - not.No RNS this morning announcing a massive deal.Lol. | ben gibbons | |
27/7/2022 06:48 | PM2022 over on LSEStock house tweet has been liked and retweeted and not refuted by Suzy therefore must be genuine.Lol what a muppet.Fact - it would have been rns'd because it's price sensitive.Fact - it has glaringly obvious grammar and spelling mistakes.Fact - PM2022 is an idiot who also thinks southerninvestor is porky on a second account when anyone who compares their conversational manner can see they are not the same person. | ben gibbons | |
26/7/2022 16:56 | Probably a fake ramp. There are some spelling mistakes as well so I think it's fake. | ben gibbons | |
26/7/2022 16:56 | That article was written at 10:31am uk time so sure it would have been rns'd if it was accurate. | ben gibbons | |
26/7/2022 16:48 | No worries link already here. | ben gibbons | |
26/7/2022 16:47 | Where did you get that from. Link please? | ben gibbons | |
26/7/2022 16:29 | Huge news if article is correct.ValiRx and TheoremRx - VAL201 - US$61M plus royaltiesDr Ken Sorensen, Chairman of TheoremRx We are delighted out latest fundraising od $250m has brought in multiple financial institutions as we now move forward with our strategic plans.Dr Ken Sorensen, Chairman of TheoremRx stated: "We have appreciated the work carried out so far, and we will now move forward with VAL201 as it is an important part of our pipeline of new projects."First payments to ValiRx are expected on or before the end of July.The proposed sub-licence of VAL201 to TheoremRx Inc. VAL201's primary indication is for prostate cancer, with potential further research & development in breast and ovarian cancer. The potential value of the deal would be in excess of US$61M plus royalties for the first cancer indication alone. Each oncology indication successfully developed to by TheoremRx will generate up to $37.5M of additional value to ValiRx. The proposed deal structure comprises payments on signature of the Licence Agreement plus fees and near-term milestones totalling US$2.2M before the end of 2023, milestones on further clinical and commercial development events, and royalties. The first payments are expected by the end of July 2022. | aimtrader2 | |
26/7/2022 11:01 | Also a saleable product Not a life style company Roll on the next 15 year's VAL .... equals Top Gun 8 release ! Lol | amaretto1 | |
26/7/2022 10:23 | Get the placing churn done and should see 20p in quick time.Went up over 500% in a few weeks after the last placing . | jungmana | |
26/7/2022 10:13 | Same old story with valirx then, not going anywhere from what I can see... Only time will tell... | tonythemanwithnoname | |
26/7/2022 09:30 | Agreed Amaretto prefers cos with huge debt and huge cash burn ..this isn't for him. | nico115 | |
26/7/2022 08:38 | GBP 10m market cap right now with cash of GBP 2.5m .Too cheap for val imo. | jungmana | |
25/7/2022 22:35 | Monkey boy the Guru on VAL ..He's been on Advfn since April 22 ... | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions